|
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 34,52 USD | -7,32% |
|
+12,02% | +7,55% |
| 15:35 | Transcript : MBX Biosciences, Inc. - Special Call | |
| 13:55 | L'essai de phase 2 de MBX Biosciences sur le canvuparatide atteint son critère d'évaluation principal ; le titre chute en avant-Bourse | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7,32% | +12,02% | -8,27% | +21,36% | +7,55% | +216,42% | - | - | - | 1,77 Md | |
| -0,35% | +0,97% | +2,55% | +1,20% | -8,83% | -15,96% | -12,73% | -26,23% | +207,01% | 42,96 Md | |
| +2,86% | +3,20% | +5,68% | +61,99% | +93,35% | +274,60% | +508,46% | +345,47% | - | 31,73 Md | |
| -1,00% | -2,06% | +2,64% | +10,28% | -20,29% | +12,91% | -15,21% | -26,50% | +174,74% | 30,22 Md | |
| +1,64% | -1,62% | -15,66% | -6,86% | -12,54% | -3,91% | +24,63% | -22,94% | +809,38% | 28,94 Md | |
| +4,09% | -1,98% | -5,04% | -13,09% | +0,36% | +11,99% | +17,37% | -20,74% | +150,45% | 23,87 Md | |
| -1,19% | +3,48% | +11,98% | +5,90% | -16,31% | +54,62% | +115,59% | +161,95% | - | 13,57 Md | |
| -0,40% | -1,29% | +8,24% | +3,92% | +2,69% | +6,06% | +7,59% | -26,45% | +100,41% | 12,96 Md | |
| +2,68% | +5,41% | -6,65% | - | - | - | - | - | - | 13,39 Md | |
| -1,08% | -1,97% | -3,71% | +0,93% | -7,70% | +104,98% | +75,39% | +93,21% | +240,08% | 12,2 Md | |
| -3,38% | -2,44% | +19,57% | +49,62% | -19,99% | -0,88% | -36,03% | -32,13% | +120,31% | 11,48 Md | |
| -2,49% | -3,95% | -27,13% | -20,00% | -8,57% | +19,51% | +3 003,28% | - | - | 9,76 Md | |
| -0,24% | +3,58% | +11,35% | +23,04% | -5,84% | +23,67% | -8,59% | -47,14% | +122,76% | 9,06 Md | |
| -4,14% | +3,54% | +2,40% | -2,94% | -18,59% | -32,51% | - | - | - | 8,9 Md | |
| -0,46% | +3,81% | +13,81% | +4,86% | -8,23% | +4,74% | -31,39% | -51,96% | +92,17% | 8,46 Md | |
| -0,12% | -3,19% | -17,98% | -17,27% | -29,36% | +1 260,80% | +450,84% | +170,86% | +861,02% | 7,82 Md | |
| -1,14% | +1,04% | +9,97% | -9,87% | -21,71% | -25,71% | -27,44% | -29,98% | +49,19% | 7,74 Md | |
| +0,70% | +5,80% | +18,26% | +63,83% | +61,84% | +47,12% | +45,04% | +83,18% | +6,62% | 7,49 Md | |
| +1,18% | +14,19% | +11,26% | +16,54% | +27,32% | +97,44% | +283,71% | +170,49% | - | 7,06 Md | |
| +6,28% | +4,58% | -22,60% | -12,44% | -9,88% | +489,90% | +1 750,05% | -14,49% | - | 6,91 Md | |
| Moyenne | -0,12% | +0,20% | +0,53% | +9,53% | +0,28% | +133,99% | +361,80% | +45,41% | +244,51% | 14,81 Md | |
| Moyenne pondérée par Capi. | +0,42% | -1,02% | +0,38% | +10,23% | +3,31% | +89,46% | +239,29% | +47,48% | +274,88% |
- Bourse
- Actions
- Action MBX
- Secteur MBX Biosciences, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
